Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
Bioorganic & Medicinal Chemistry Letters|April 15, 2014
Discovery and SAR of a novel series of 2,4,5,6-tetrahydrocyclopenta[c]pyrazoles as N-type calcium channel inhibitorsMichael P Winters, Nalin Subasinghe, Mark Wall, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 13, 2007
Neuropharmacological profile of novel and selective 5-HT6 receptor agonists: WAY-181187 and WAY-208466Lee E Schechter, Qian Lin, Deborah L Smith, et al.Pharmacology, Biochemistry, and Behavior|May 5, 2010
Ex vivo delta opioid receptor autoradiography: CNS receptor occupancy of two novel compounds over their antihyperalgesic dose rangeEllen E Codd, Jianya Ma, Sui-Po Zhang, et al.Bioorganic & Medicinal Chemistry Letters|October 20, 2018
Discovery and optimization of a novel series of pyrazolyltetrahydropyran N-type calcium channel (Ca<sub>v</sub> 2.2) blockers for the treatment of painMark J Wall, Nalin L Subasinghe, Michael P Winters, et al.Bioorganic & Medicinal Chemistry Letters|May 22, 2012
A novel series of pyrazolylpiperidine N-type calcium channel blockersNalin L Subasinghe, Mark J Wall, Michael P Winters, et al.Bioorganic & Medicinal Chemistry Letters|June 13, 2020
The discovery of azetidine-piperazine di-amides as potent, selective and reversible monoacylglycerol lipase (MAGL) inhibitorsBin Zhu, Peter J Connolly, Yue-Mei Zhang, et al.Bioorganic & Medicinal Chemistry Letters|March 25, 2008
N-pyridin-3-yl- and N-quinolin-3-yl-benzamides: modulators of human vanilloid receptor 1 (TRPV1)Michele C Jetter, James J McNally, Mark A Youngman, et al.Bioorganic & Medicinal Chemistry Letters|March 17, 2012
The design and synthesis of novel, phosphonate-containing transient receptor potential melastatin 8 (TRPM8) antagonistsJay M Matthews, Ning Qin, Raymond W Colburn, et al.Bioorganic & Medicinal Chemistry Letters|February 16, 2013
Arylglycine derivatives as potent transient receptor potential melastatin 8 (TRPM8) antagonistsBin Zhu, Mingde Xia, Xiaoqing Xu, et al.Journal of Medicinal Chemistry|January 17, 2009
Prodrugs of perzinfotel with improved oral bioavailabilityReinhardt B Baudy, John A Butera, Magid A Abou-Gharbia, et al.Pageof 3